NEAT1是逆转T细胞耗尽在膀癌的治疗点
Kun Li1, Lixin Niu2, Xufei Zhang2
1Nuclear Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Journal for immunotherapy of cancer
|December 3, 2025
概括
核斑组合转录1 (NEAT1) 是膀癌中T细胞耗尽的关键调节者. 向NEAT1可以逆转T细胞耗尽并提高癌症免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 瘤微环境中的T细胞耗尽阻碍了癌症免疫疗法.
- 目前的免疫检查点抑制剂由于非目标效应和单一目标而存在局限性.
- 识别新目标来调节多个免疫检查点对于有效的癌症治疗至关重要.
研究的目的:
- 为了研究核光组合转录1 (NEAT1) 在膀瘤微环境中的T细胞耗尽中的作用.
- 确定NEAT1影响免疫检查点基因表达和T细胞功能的分子机制.
主要方法:
- 在NSG小鼠中利用了人类膀癌的异种移植模型.
- 通过RNA净化,染色体免疫沉和光酶试验采用了染色体隔离.
- 研究了NEAT1与乳酸脱酶A和免疫检查点基因的相互作用.
主要成果:
- NEAT1是一种与膀癌相关的长非编码RNA (lncRNA),在瘤细胞中促进乳酸的产生.
- 乳酸生产抑制了CD8+T细胞中NEAT1的表达,影响了它们的抗瘤功能.
- NEAT1通过改变组织蛋白乳化直接结合并抑制多个免疫检查点基因的转录.
结论:
- lncRNA NEAT1在膀瘤微环境中调节CD8+T细胞的抗瘤反应.
- 在癌症免疫疗法中,NEAT1代表了克服T细胞耗尽的潜在治疗标.
- 向NEAT1可能通过恢复T细胞功能来提高癌症治疗的疗效.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K